Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Robust antibody and cellular responses induced by DNA-only vaccination for HIV
Stephen C. De Rosa, Srilatha Edupuganti, Yunda Huang, et al.
JCI Insight (2020) Vol. 5, Iss. 13
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial
Pablo Tebas, ShuPing Yang, Jean Boyer, et al.
EClinicalMedicine (2020) Vol. 31, pp. 100689-100689
Open Access | Times Cited: 258
Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial
Mark Yarchoan, Edward Gane, Thomas U. Marron, et al.
Nature Medicine (2024) Vol. 30, Iss. 4, pp. 1044-1053
Open Access | Times Cited: 45
COVID-19 Vaccines: “Warp Speed” Needs Mind Melds, Not Warped Minds
John P. Moore, Per Johan Klasse
Journal of Virology (2020) Vol. 94, Iss. 17
Open Access | Times Cited: 92
DNA Vaccines: History, Molecular Mechanisms and Future Perspectives
Sthefany Pagliari, Bárbara Dema, Alexandra Sánchez-Martínez, et al.
Journal of Molecular Biology (2023) Vol. 435, Iss. 23, pp. 168297-168297
Open Access | Times Cited: 22
Advanced Micro/Nano-Electroporation for Gene Therapy: Recent Advances and Future Outlook
Feng liu, Rongtai Su, Xinran Jiang, et al.
Nanoscale (2024) Vol. 16, Iss. 22, pp. 10500-10521
Closed Access | Times Cited: 7
Intradermal-delivered DNA vaccine provides anamnestic protection in a rhesus macaque SARS-CoV-2 challenge model
Ami Patel, Jewell Walters, Emma L. Reuschel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Closed Access | Times Cited: 61
Intradermal-delivered DNA vaccine induces durable immunity mediating a reduction in viral load in a rhesus macaque SARS-CoV-2 challenge model
Ami Patel, Jewell Walters, Emma L. Reuschel, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 10, pp. 100420-100420
Open Access | Times Cited: 51
HIV vaccinology: 2021 update
Jeong Hyun Lee, Shane Crotty
Seminars in Immunology (2021) Vol. 51, pp. 101470-101470
Open Access | Times Cited: 44
Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: a preliminary report of a randomized, blinded, placebo-controlled, Phase 2 clinical trial in adults at high risk of viral exposure
Mammen P. Mammen, Pablo Tebas, Joseph Agnes, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 42
The cytokine/chemokine response in Leishmania/HIV infection and co-infection
Semer Maksoud, Joelle El Hokayem
Heliyon (2023) Vol. 9, Iss. 4, pp. e15055-e15055
Open Access | Times Cited: 19
Vaccine delivery systems and administration routes: Advanced biotechnological techniques to improve the immunization efficacy
Abdellatif Bouazzaoui, Ahmed A. H. Abdellatif
Vaccine X (2024) Vol. 19, pp. 100500-100500
Open Access | Times Cited: 5
Harnessing Recent Advances in Synthetic DNA and Electroporation Technologies for Rapid Vaccine Development Against COVID-19 and Other Emerging Infectious Diseases
Ziyang Xu, Ami Patel, Nicholas J. Tursi, et al.
Frontiers in Medical Technology (2020) Vol. 2
Open Access | Times Cited: 35
Comparative immunogenicity of an mRNA/LNP and a DNA vaccine targeting HIV gag conserved elements in macaques
Antonio Valentin, Cristina Bergamaschi, Margherita Rosati, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
Electrotransfer for nucleic acid and protein delivery
Aswin Muralidharan, Pouyan E. Boukany
Trends in biotechnology (2023) Vol. 42, Iss. 6, pp. 780-798
Open Access | Times Cited: 9
New insights for the development of efficient DNA vaccines
Simone Berger, Yanira Zeyn, Ernst Wagner, et al.
Microbial Biotechnology (2024) Vol. 17, Iss. 11
Open Access | Times Cited: 2
New vector and vaccine platforms: mRNA, DNA, viral vectors
Tomáš Hanke
Current Opinion in HIV and AIDS (2022) Vol. 17, Iss. 6, pp. 338-344
Open Access | Times Cited: 12
Intramuscular and Intradermal Electroporation of HIV-1 PENNVAX-GP® DNA Vaccine and IL-12 Is Safe, Tolerable, Acceptable in Healthy Adults
Srilatha Edupuganti, Stephen C. De Rosa, Marnie Elizaga, et al.
Vaccines (2020) Vol. 8, Iss. 4, pp. 741-741
Open Access | Times Cited: 18
One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model
Karen E. Gooch, Trevor R.F. Smith, Francisco J. Salguero, et al.
Vaccine (2021) Vol. 39, Iss. 34, pp. 4885-4894
Open Access | Times Cited: 17
Mucosal chemokine adjuvant enhances synDNA vaccine-mediated responses to SARS-CoV-2 and provides heterologous protection in vivo
E. Gary, Nicholas J. Tursi, Bryce M. Warner, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 7, pp. 100693-100693
Open Access | Times Cited: 10
Control of SARS-CoV-2 infection after Spike DNA or Spike DNA+Protein co-immunization in rhesus macaques
Margherita Rosati, Mahesh Agarwal, Xintao Hu, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 9, pp. e1009701-e1009701
Open Access | Times Cited: 13
Intradermal delivery of a synthetic DNA vaccine protects macaques from Middle East respiratory syndrome coronavirus
Ami Patel, Emma L. Reuschel, Ziyang Xu, et al.
JCI Insight (2021) Vol. 6, Iss. 10
Open Access | Times Cited: 12
Gene‐encoded nanoparticle vaccine platforms for in vivo assembly of multimeric antigen to promote adaptive immunity
Nicholas J. Tursi, Ziyang Xu, Daniel W. Kulp, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2023) Vol. 15, Iss. 4
Open Access | Times Cited: 4
Cellular and humoral responses to an HIV DNA prime by electroporation boosted with recombinant vesicular stomatitis virus expressing HIV subtype C Env in a randomized controlled clinical trial
Gregory J. Wilson, Benigno Rodríguez, Shuying Sue Li, et al.
Vaccine (2023) Vol. 41, Iss. 16, pp. 2696-2706
Open Access | Times Cited: 4
Flow cytometry as an integrative method for the evaluation of vaccine immunogenicity: A validation approach
Elena Gianchecchi, Alessandro Torelli, Pietro Piu, et al.
Biochemistry and Biophysics Reports (2023) Vol. 34, pp. 101472-101472
Open Access | Times Cited: 4
Generating and measuring effective vaccine-elicited HIV-specific CD8+ T cell responses
Gina M. Borgo, Rachel L. Rutishauser
Current Opinion in HIV and AIDS (2023) Vol. 18, Iss. 6, pp. 331-341
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top